Category Archives: Cancer and neoplasms

Children’s health in Cyprus ‘alarming’

The alarmingly poor level of children’s health on the island was highlighted by presenters at the 9th Cyprus Public Health Day conference held at Tepak’s international institute for environmental and public health (CII). According to paediatric health experts Cyprus, along with Greece, holds the negative lead among countries in Europe for childhood obesity and associated […]

Multi-Institutional Study Data Presented at ASTRO 2023 Builds Upon Growing Evidence of GammaTile for Patients with Brain Tumors

October 3, 2023 — Medical device company GT Medical Technologies, Inc. announced interim findings of a multi-institutional study that demonstrates high local control for the treatment of recurrent brain metastases in patients. The findings add to the growing evidence of the efficacy and safety of its FDA-approved GammaTile Therapy, and were presented during an Oct. […]

Florida veterinary school pioneers canine heart surgery program

Michael Aherne, MVB (Hons 1), GradDipVetStud, MS, MANZCVS (Small Animal Surgery), DACVIM (Cardiology); Darcy Adin, DVM; and Katsuhiro Matsuura, DVM, PhD, members of the UF College of Veterinary Medicine’s open heart surgery team. They are posing with their first patient, George, held by his owner, Kimberley David (second from the right) before George’s discharge on […]

Blood Cancer UK | What can we achieve with £1 million?

4th Oct 2023 – Dr Sammy Eden United Kingdom From targeted treatments to shrinking side-effects, we’re proud to announce we’ve invested over £1,000,000 funding five research projects, across five different blood cancers. Here’s what our researchers are looking to achieve. Our 5 new researchers i 1. Better ways of screening for blood cancers Our new […]

NanoRevolution: Unveiling the Future of Cancer Care with a 13.8% CAGR from 2023-2030

The Cancer Nanotechnology Market, valued at USD 33,835.12 million in 2022, is poised for a substantial upswing with an expected Compound Annual Growth Rate (CAGR) of 13.8% during the forecast period from 2023 to 2030. Nanotechnology has emerged as a groundbreaking approach, offering precise and targeted therapies for cancerous cells and neoplasms. This transformative technology […]

Screening History and Long-Term Survival in CRC patients

Introduction Colorectal cancer is the third most common cancer worldwide in terms of incidence and mortality.1 The age-standardized incidence and mortality rate for colorectal cancer in Taiwan, which were 38.1 and 12.4 (per 105) in 2019, respectively, are higher than those in Japan and Korea, and both rates have been increasing.2,3 Screening, a crucial intervention […]

Biodexa Completes Recruitment of Cohort A in Study of MTX110 in Patients with Recurrent Glioblastoma

Biodexa Pharmaceuticals PLC(“Biodexa” or the “Company”) Biodexa Completes Recruitment of Cohort A in Study of MTX110 in Patients with Recurrent Glioblastoma Biodexa Pharmaceuticals PLC, (Nasdaq: BDRX), a clinical stage biopharmaceutical company developing a pipeline of products aimed at primary and metastatic cancers of the brain, is pleased to announce that it has completed recruitment into […]

IgA Nephropathy Market to Exhibit Growth at a Tremendous CAGR of ~20% by 2032

New York, USA, Oct. 03, 2023 (GLOBE NEWSWIRE) — IgA Nephropathy Market to Exhibit Growth at a Tremendous CAGR of ~20% by 2032 | DelveInsight As potential therapies with novel mechanisms are being investigated to improve the management of IgAN, it is safe to predict that the IgA nephropathy market space will experience significant growth […]